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Abstract

Kaushik, Gayathri. M.S. The University of Memphis. August/2013. Ovarian
dynamics in zebrafish (Danio rerio): A study of growth, vascularization, and estrogenic
effects in follicle-enclosed oocytes in vivo. Major Professor: Dr. Charles A. Lessman
The timeline of follicle-enclosed oocyte growth and development is not known.
To study this, mature female zebrafish, Danio rerio, were injected intraperitoneally with
the marker trypan blue (TB). Ovaries were removed at different time post injection. Then,
oocyte diameter and TB uptake were determined from brightfield and fluorescence
microscopy images, respectively. TB uptake increased steadily up to 48 hours post
injection and declined subsequently. In Tg(fli1:EGFP)y1 zebrafish that express green
fluorescent protein in endothelial cells, ovarian blood vessel diameter was greater in
larger oocytes and unaffected by in vitro treatments with vasoactive agents. In the
transparent zebrafish, casper, oocytes naturally cycled between growth and regression in
vivo. Exogenous estradiol and tamoxifen both disrupted the cycle and maintained ovaries
in the regressed phase. Surprisingly, stopping the hormone treatment, restored the natural
cycle. Together, these studies provide the foundation and tools for future experiments on
oocyte development in zebrafish.
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Introduction

Oogenesis is a dynamic process that defines the various stages of follicle-enclosed
oocyte development leading to the formation of a mature egg (Lessman, 1999, 2009;
Lubzens et al., 2010; Selman, 1993; Selman and Wallace, 1983; Wallace and Selman,
1985) (Fig. 1). Several studies provide extensive information on the structural
development of follicle-enclosed oocytes and the role of various ovarian cells involved in
teleost oogenesis (Davail et al., 1998; Droller and Roth, 1966; Shaner et al., 2004;
Wallace and Selman, 1985). Further, these studies also provide details on the role of
hormones in follicle-enclosed oocyte development.
In teleost fish, follicle-enclosed oocyte development starts with the
previtellogenic phase (stages 1 and 2) and continues with the vitellogenic phase (stage 3).
During the vitellogenic phase, the yolk precursor, vitellogenin, and other nutrients are
incorporated and this leads to significant increase in the size of the follicle-enclosed
oocyte (Clelland and Peng, 2009; Lessman, 1999, 2009; Lubzens et al., 2010; Matsuda et
al., 2011; Selman and Wallace, 1983). Further growth of the follicle-enclosed oocyte
results in its meiotic maturation followed by ovulation and oviposition which prepares the
female gamete for fertilization (Fig. 1) (Lessman, 2009; Lubzens et al., 2010; Selman,
1993). However, the time course of ovarian follicle development and vitellogenin uptake
during the vitellogenic phase is not completely known.
Vitellogenic phase includes the production of vitellogenin (Lessman, 2009;
Polzonetti-Magni et al., 2004) and its incorporation into the follicle-enclosed oocyte
together with lipids and vitamins (Lubzens et al., 2010). Vitellogenin is a bulky
phospholipoglycoprotein (250-600KDa) molecule found in female teleosts and other
1

vertebrates that lay yolk-filled eggs. Vitellogenin is mainly synthesized in the liver, and
in small amounts in other organs such as the ovary (Lubzens et al., 2010; Wang et al.,
2005). After synthesis, vitellogenin reaches the ovaries via the blood stream. Follicleenclosed oocytes take up vitellogenin by receptor mediated endocytosis. The endocytic
vesicles fuse with lysosomes to form yolk globules (Fig. 2), which have a crystalline core
of lipovitellin and phosvitin that have been processed from the endocytosed vitellogenin
(Lessman, 2009; Okumura et al., 2002; Wallace and Selman, 1985, 1990). However, the
specific time course for vitellogenin uptake and incorporation during development of the
follicle-enclosed oocyte is not known.
Uptake of vitellogenin into follicle-enclosed oocytes in vivo occurs in an intact
ovarian follicle that consists of a layer of follicle cells surrounding the oocyte, which in
turn is surrounded by a stromal layer of theca cells and an outer layer of epithelial cells
(Fig. 3). The follicle and theca cells are involved in the synthesis of steroid hormones
(Fig. 3). The ovarian follicle is surrounded by blood vessels, which assist in transporting
vitellogenin to the follicle for uptake into oocytes. The effect of steroid hormones or
other neurotransmitters secreted during the oocyte development on follicle angiogenesis
has not been studied in zebrafish.
Estradiol is a major hormone involved during the vitellogenic phase in the
development of the follicle-enclosed oocyte (Clelland and Peng, 2009; Lessman, 1999;
Lessman and Habibi, 1987; Lubzens et al., 2010; Miura et al., 2007). The primary role of
estradiol is to control production of vitellogenin from the liver (Clelland and Peng, 2009).
In addition, estradiol may have effects on yolk formation and proliferation of follicleenclosed oocytes as shown using in vitro experiments (Khoo, 1979; Miura et al., 2007),
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but the effects may not be directly induced by estradiol (Cerda et al., 1998). However, the
role of estradiol in oocyte development and its specific effects on the various stages of
oocyte development have not been well studied in zebrafish.
Based on the above, the current understanding of follicle-enclosed oocyte
development is especially limited in three major aspects and these are given as the major
research aims indicated below:
(1) determine the time-course of vitellogenin uptake in follicle enclosed oocytes of
different size classes,
(2) determine the relationship between ovarian vascular development and development
of follicle-enclosed oocytes and,
(3) determine the effect of estradiol in the development of follicle-enclosed oocytes.
These issues remain largely unexplored in zebrafish (Danio rerio), even though
zebrafish are touted as an important model organism. Hence, this study utilized zebrafish
to help rectify this discrepancy in this important animal model. Zebrafish is a tropical
fish, native to India and Burma. Adult zebrafish are 40 to 50 mm long and weigh up to
1.5 g. Zebrafish are used extensively in genetic, general and developmental biology
research (Levi et al., 2009; Segner, 2009; Spitsbergen et al., 2009; Spitsbergen and Kent,
2003; Tong et al., 2004), particularly because developing embryos can be observed
readily through the transparent egg chorion (Laale, 1977). Also, zebrafish genome is
sequenced and available online (http://www.ncbi.nlm.nih.gov/genome?term=daniorerio).
Ovarian development in zebrafish is asynchronous, where all stages of follicle
development are present without a dominant population (Lessman, 1999; Wallace and
Selman, 1980). In asynchronous ovulators, also called batch spawners, yolked oocytes
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ovulate and mature into eggs in several batches during the spawning season. Thus,
zebrafish produce small batches of eggs almost daily, and a large number of eggs (>150
eggs) are produced every 5 to 10 days. Zebrafish embryos hatch in about 3 days at 28°C
(Ankley and Johnson, 2004). These characteristics differ from that of other teleost fish
such as, killifish, trout, and medaka (Ankley and Johnson, 2004; Lessman and Habibi,
1987; Selman and Wallace, 1983; Tong et al., 2004; Wallace and Selman, 1985). Thus,
studies of the timeline of follicle-enclosed oocyte development, vascular development
and the effect of estradiol in zebrafish will add to our understanding of the reproductive
biology of this important model organism.
Establishing the time course of vitellogenin endocytosis in various size classes of
follicle-covered oocytes requires a marker that allows visualization of uptake by the
zebrafish oocyte. Trypan blue (TB) is a vital stain that is blue under brightfield
conditions. TB can also bind to proteins, and under these conditions fluoresces red when
excited with green light. The dye is generally used to distinguish live from dead cells due
to its inability to enter most live cells. Thus, under bright field conditions, TB-stained
dead cells appear blue. Yet, exposing live vitellogenic ovarian follicles to TB causes its
incorporation into oocytes (Anderson and Telfer, 1970; Danilchik and Denegre, 1991). In
addition, in these follicles, TB is also present between epithelial cells, suggesting that the
dye follows the path used by vitellogenin (Anderson and Telfer, 1970) through the
various layers of the ovarian follicle. Though the studies have been done using insect
(Anderson and Telfer, 1970) and frog oocytes (Danilchik and Denegre, 1991), the rapid
uptake of TB from the maternal blood circulation and its deposition in oocytes in a
manner similar to vitellogenin, suggest that TB enters the follicle-covered oocyte with
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vitellogenin. Preliminary data in zebrafish indicated that TB fluorescence was restricted
to yolk vesicles with no detectable signal in the oocyte cytosol, and in resulting embryos
the yolk cell fluoresces while the non-yolky portions do not fluoresce.
In addition, quantifying vascular development requires visualizing ovarian blood
vessels. The Tg(fli1:EGFP)y1 transgenic zebrafish expresses the green fluorescent
protein (GFP) in the vascular endothelium (Lawson and Weinstein, 2002). The EGFP
expression is driven by the promoter for fli1, an endothelial marker that is present during
vascular development in zebrafish. Preliminary experiments showed that ovarian vessels
of Tg(fli1:EGFP)y1 zebrafish could be visualized by fluorescence microscopy.
Further, establishing changes in ovarian morphology requires visualizing them in
the intact zebrafish. The casper double mutant zebrafish lacks all melanocytes and
iridiophores and thus, is almost entirely transparent (White et al., 2008). In adult female
casper zebrafish, individual follicles can be easily observed.
Thus, in wild type and transgenic zebrafish models, TB was used to follow the
development of follicle-enclosed oocytes and ovarian blood vessels. In addition, the
transgenic and mutant zebrafish were also used to determine the role of hormones on
ovarian development in vivo.

5

Materials and Methods

Zebrafish
Adult wild-type (Danio rerio) were reared at 28°C on a 14 hr photoperiod cycle,
and fed Tetramin daily, supplemented with freeze-dried brine shrimp (Artemia). The
water in the spawning tanks was changed daily. Male and female fish were housed
together in the spawning tanks. Spawning was checked daily and embryos were collected.
In addition, two additional zebrafish lines obtained as a gift from Dr. Michael R.
Taylor, St. Jude Children’s Research Hospital, Memphis, TN were also reared for the
present studies. 1) A GFP-transgenic Tg(fli1:EGFP)y1 zebrafish; the endothelial cells of
this transgenic fish express green fluorescent protein (GFP) and hence, can be visualized
by fluorescence microscopy (Lawson and Weinstein, 2002). 2) casper, named for its
ghost-like appearance, lacks all melanocytes and iridiophores and thus, the body is almost
entirely transparent (White et al., 2008). The casper fish was generated from the nacre
mutant that lacks melanocytes due to mutation in the gene encoding the mitfa gene (Lister
et al., 1999) and the roy orbison (roy) zebrafish, which is a spontaneous mutant and lacks
iridophores (White et al., 2008). In adult female casper zebrafish, individual follicles can
be easily observed. Maintenance and breeding of both the Tg(fli1:EGFP)y1 and casper
zebrafish were carried out as described for wild-type zebrafish above.

Intraperitoneal Injection
Adult female zebrafish in spawning condition were anesthetized with 0.04%
tricaine methanesulfonate (0.1 mg in 250 ml) in egg water (reverse osmosis purified
water containing 3 drops 1% methylene blue per 4L) and weighed. The fish were
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positioned in a custom-made device consisting of a plastic dropper cut lengthwise and
attached to a microscope slide with cyanoacrylic adhesive (superglue). This slide was
then placed in the bottom of a 100mm Petri dish filled with saline. A syringe filled with
the injectate was fitted with a 30 gauge needle and the assembly was placed in a
micromanipulator. With the aid of a dissecting microscope, the needle was inserted into
the IP cavity of the anesthetized zebrafish. The chemical was then injected intraperitoneal
cavity, dental adhesive powder was placed over the injection site as a wound dressing,
and the fish was allowed to recover from anesthesia and returned to its tank.
Markers that were injected into the zebrafish are described below. The fluorescent
marker, trypan blue (Sigma Aldrich, St. Louis, MO) (0.2 grams) was dissolved in 20 ml
Cortland’s fish saline (Wolf, 1969) containing 29 gram NaCl, 0.92 gram CaCl2, 1.52
gram KCl2, and 0.92 gram MgSO4, pH 7.4 adjusted with HCl and NaHCO3. The 1%
solution (1gm TB dissolved in 100ml Cortland’s saline) was transferred to a dialysis tube
and dialyzed overnight against Cortland’s saline to remove small impurities. Prior to
injecting TB into zebrafish, the 1% stock solution of TB in some experiments was diluted
1:1 (0.5%) or 1:4 (0.25%) with Cortland’s saline.
Other fluorescent markers used include FITC-lectin (0.1 mg/ml) from EY Labs
(San Mateo, CA), FITC-casein (0.5 mg/ml) from Anaspec Inc. (Freemont, CA), and
mCherry (1 mg/ml) from BioVision Inc (Milpitas, CA). These markers were also
dissolved in Cortland’s saline and injected as described above.
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Microscopy
To visualize zebrafish ovaries, the fluorescent-marker-treated zebrafish were
anesthetized in tricaine methanesulfonate and sacrificed by decapitation. The ovaries
were removed and placed on a glass depression slide filled with Cortland’s saline.
Brightfield microscopy: Slides were placed on a Nikon upright microscope
(Eclipse E400) trans-illuminated by a halogen lamp and viewed with either a 4x air
objective (NA 0.13) or a 10x objective (NA 0.25). Images were captured using a Canon
digital camera attached to the camera port of the microscope.
Fluorescence microscopy: For fluorescence visualization of zebrafish ovary, the
epi-illumination setup on the Nikon microscope was used, which included a mercury
lamp and interchangeable UV, blue and green interference filter sets. This allowed
excitation of the ovaries in slides with either UV (wavelength about 350 nm), blue
(wavelength about 485 nm) or green (wavelength about 540 nm) light. The blue, green or
red emission, respectively, was viewed using either the 4 or 10X air objective and the
images captured with a Canon digital camera.
The excitation and emission filter sets used for the various fluorescent markers are
noted below.
Fluorescent marker

excitation filter set

emission filter set

Trypan blue

green

red

FITC-lectin

blue

green

FITC-casein

blue

green

mCherry

green

red
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As GFP has a major excitation peak at 488 nm and peak emission at 509 nm
(Heim et al., 1995), the blue excitation interference filter set and green emission filer set
were used to visualize and image ovaries dissected from Tg(fli1:EGFP)y1 zebrafish.

Estimating Protein-Trypan Blue Binding
An in vitro assay was performed to determine TB binding to proteins. Different
concentrations of TB were mixed in a 96-well plate with different concentrations of
bovine serum albumin (BSA). Then, the plate was epiilluminated with the green
excitation filter set of a fluorescence microscope and observed with a 4x objective. A
Canon camera was used to capture the emitted fluorescence and the same exposure
setting was used for all the wells. The fluorescence intensity in each well was determined
using ImageJ and the results were plotted.

Analysis Methods
The brightfield and fluorescence digital images from the Canon digital camera
were downloaded into a computer as .jpg files. These image files were analyzed using
ImageJ image analysis software (http://rsb.info.nih.gov/ij/). To quantify distances, an
image of a stage micrometer was captured and used to calibrate length in ImageJ.
Fluorescence digital images were split into red, blue and green channels in ImageJ. It is
possible that fluorescence emission in a specific channel is contaminated by emission in
other channels. Hence, separating the channels and using only the color channel specific
to a fluorescent marker may minimize this contamination.
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Ovarian Follicle Diameter Measurement
Ovarian follicular diameter was determined from brightfield images. In these
images, ovarian follicles that were in sharp focus were selected. At the maximum
diameter location, a line was drawn across the ovarian follicle using a calibrated Line
Tool in ImageJ. The length of the line was then calculated from ImageJ and recorded in
Microsoft Excel as the diameter of the ovarian follicle.

Ovarian Follicle Fluorescence Intensity Measurement
The fluorescence intensity within ovarian follicles was determined from the
respective channel of the fluorescence image. Fluorescence intensity of TB in ovarian
follicles was determined using the red channel after splitting the fluorescence image as
described above. A line was drawn across an oocyte at midline with the calibrated line
tool in ImageJ. The average fluorescence intensity along that line was recorded in
Microsoft excel from ImageJ as the mean fluorescence intensity of that ovarian follicle.
For FITC-lectin and FITC-casein, the green channel was used, while for mCherry the red
channel was used.

Quantifying Ovarian Follicular GFP Fluorescence
To determine the percentage of GFP in ovarian follicles dissected from
Tg(fli1:EGFP)y1 transgenic zebrafish, the green channel of the split fluorescence image
was used. The GFP signal threshold was adjusted after background subtraction and a
calibrated Circle tool from ImageJ was used to draw a circle within the vascularized
region of a follicle-enclosed oocyte. The fluorescence intensity within this circular region
was recorded in Microsoft Excel from ImageJ as the mean percent of thresholded GFP
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fluorescence per unit calibrated area within the vascularized region of that ovarian
follicle.

Ovarian Follicle Blood Vessel Diameter Measurement
The green channel of the split fluorescence image was used to determine the
diameter of blood vessels on ovarian follicles dissected from Tg(fli1:EGFP)y1 transgenic
zebrafish,. The brightness and contrast of the image was adjusted to optimized levels and
a vessel that was in sharp focus was selected. Using the calibrated Line Tool of ImageJ, a
line was drawn along the cross-section of the vessel. The length of the line was recorded
in Microsoft Excel from ImageJ as the diameter of the blood vessel. This process was
repeated at about 20 sites along the vessel length and the mean diameter for the vessel
was calculated.

Exogenous Hormone Treatment
Zebrafish were treated with exogenous hormones to determine the effect of
hormone treatment on ovarian follicle development. The appropriate agent was added to
the spawning tank containing the female zebrafish to be studied. After 2 days, TB was
injected intraperitoneally, as described above. Following incubation of different
durations, the zebrafish were removed, the ovaries were dissected and the various
measurements made as described above.
In this study, the effect of exogenous estradiol and tamoxifen were studied. These
hormones were purchased from Sigma Aldrich. Estradiol was added to the spawning
tank at 1 µg/L and10 µg/L, while tamoxifen was added to the spawning tank at
concentrations, 5 µg/L and 50 µg/L.
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In vitro Drug Treatment of Ovarian Follicles
The effect of in vitro treatment of drugs on ovarian follicle blood vessel diameter
were determined in ovarian follicles dissected from zebrafish as described above. The
ovarian follicles were placed under a microscope and imaged as described above. The
desired drug was administered and images of the ovarian follicle were taken both before
and after administering the drug. The images were then analyzed as described above.
In this study, the effect of in vitro treatment of ovarian follicles with estradiol,
epinephrine, histamine and acetylcholine was studied. These hormones were purchased
from Sigma Aldrich and used at the following concentrations; estradiol (37 µg/ml),
epinephrine (183.2 µg/ml), histamine (13.3 mg/ml ) and acetylcholine (66 µg/ml).

Statistical Analysis
Relationships between follicle diameter and TB fluorescence intensity as well as
follicle diameter versus blood vessel diameter were analyzed by regression lines and by
computing Pearson r coefficients. ANOVA was used to analyze blood vessel diameter
changes with time and drug treatment with significance assigned at p < 0.05.
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Results

1. Time course of vitellogenin uptake in follicle-enclosed oocytes

Trypan blue (TB) uptake in wildtype zebrafish as a function of ovarian follicle diameter
(size class)
Wildtype zebrafish injected with TB were sacrificed at 1, 24, 48, and 96 hour
post-injection. The ovary was then removed, and both bright-field and fluorescence
images of follicle-enclosed oocytes were taken, as shown for a representative follicleenclosed oocyte in Fig. 4. From these images, the diameter and TB fluorescence intensity
of the follicle-enclosed oocytes were determined as described in Materials and Methods.
To determine background fluorescence in follicle-enclosed oocytes, bright-field
and fluorescence images were obtained using wildtype zebrafish that did not receive any
TB injection (Fig. 5A). From the images in this Figure, it can be seen that background
fluorescence was low. Background fluorescence plotted as a function of oocyte diameter
showed that the fluorescence was low across all size classes of follicle-enclosed oocytes
(Fig. 5B).
In wildtype zebrafish injected with TB and sacrificed at 1 hour post-injection, the
fluorescence of TB was detectable in follicle-enclosed oocytes (Fig. 6A). However, the
TB fluorescence was higher than background only in a small number of follicle-enclosed
oocytes. Also, the fluorescence remained low across all size classes of follicle-enclosed
oocytes and did not vary as a function of their diameter (Fig. 6B).
In follicle-enclosed oocytes dissected 24 hours after TB injection, the TB
fluorescence was seen in a larger number of oocytes than compared to those dissected at
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1 hour (Fig. 7A). However, the fluorescence increase was small and limited to a small
size class of oocytes. The fluorescence also did not vary much as a function of follicleenclosed oocyte diameter (Fig. 7B).
In contrast, in follicle-enclosed oocytes examined 48 hours after TB injection, the
TB fluorescence was prominent and visible in a larger number of oocytes (Fig. 8A). This
higher fluorescence was seen over a wider range of oocyte diameters. Also, the
fluorescence increase with diameter was high (r = 0.75) (Fig. 8B). Most of the follicleenclosed oocytes that exhibited high fluorescence were in the 300-500 micron diameter
range. At 96 hours post TB injection, the fluorescence decreases overall and this
decrease is seen for follicle-enclosed oocytes of all diameters (Fig. 9).

TB uptake in Tg(fli1:EGFP)y1 zebrafish
As similar to wildtype zebrafish, the background fluorescence was very low in
ovarian follicles dissected from Tg(fli1:EGFP)y1 zebrafish not administered any TB (Fig.
10). At 24 hours post injection, the TB fluorescence was higher than background and
similar across various follicle-enclosed oocyte diameters (Fig. 11). In this and other
similar experiments, data from fish treated similarly were pooled together as variations in
responses among fish were small. However, at 48 hours post injection TB fluorescence
was high and approached saturation in several oocytes (Fig. 12). The highest fluorescence
was mainly evident in follicle-enclosed oocytes in the diameter range of 300-500 microns
(Fig. 12). Also, the increase in fluorescence with oocyte diameter was steep (r=0.76),
suggesting that the fluorescence was highest in oocytes that were in the vitellogenic
phase.
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In follicle-enclosed oocytes examined 96 hours after TB injection, fluorescence in
all follicles declined as compared to that in oocytes examined 48 hours post injection
(Fig. 13). Moreover, the highest fluorescence was also lower. This result suggested that
the highest TB fluorescence was evident in follicle-enclosed oocytes examined at 48
hours after TB injection.
In addition, TB fluorescence was determined in follicle-enclosed oocytes 8 and 14
days after injection in Tg(fli1:EGFP)y1 zebrafish. At both these time points the
fluorescence in ovarian follicles had declined further (Figs. 14 and 15). By 14-days, the
fluorescence was close to background levels.

Trypan Blue Binding to Proteins
Injection of TB into the peritoneal cavity of zebrafish resulted in an increase in
fluorescence in the follicle-enclosed oocytes. An in vitro assay of TB-bovine serum
albumin binding was performed to determine if the fluorescence increase was due to
native unbound TB or protein-bound TB. Changes in TB fluorescence as a function of
albumin concentration were plotted for various TB concentrations (Fig. 16). From the
plot is can be seen that when no TB is present, no fluorescence was evident at all BSA
concentrations indicating that albumin had no native fluorescence. Similarly, when no
albumin was present in the solution, the trypan fluorescence was low and similar to
background at all TB concentrations indicating that TB does not fluoresce in the absence
of BSA. However, in the presence of TB in the solution, the fluorescence increases
steadily with increasing BSA concentrations.
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Uptake characteristics of other fluorescent probes
In wildtype zebrafish injected individually with FITC-casein, FITC-lectin, and
mCherry, no fluorescence emission was detectable in the follicle-enclosed oocytes for all
three probes (Figs. 17A, B).

2. Blood vessel diameter - ovarian follicle diameter relationship
To determine if ovarian blood vessels can be visualized using GFP fluorescence,
follicle-enclosed oocytes dissected from Tg(fli1:EGFP)y1 zebrafish were visualized by
confocal microscopy. Blood vessels of Tg(fli1:EGFP)y1 zebrafish express EGFP and so
the vessels can be visualized using GFP fluorescence. Images in (Fig. 18A) show that
GFP fluorescence in ovarian blood vessels was detectable.
Using GFP fluorescence images obtained using fluorescence microscopes
together with brightfield images of the follicle-enclosed oocytes indicated that blood
vessel diameter increased together with oocyte diameter (Fig. 18B). However, this
relationship was not directly proportional suggesting that follicle-enclosed oocytes with
similar size classes had blood vessels with a wide-range of diameters. Also, the
percentage of GFP fluorescence measured per unit area within the vascularized region of
ovarian follicles extracted from Tg(fli1:EGFP)y1 zebrafish did not vary as a function of
ovarian diameter (Fig. 19).
While the majority of follicle blood vessels were thought to be in the capillary
size class and thus without significant smooth muscle investments, increasing evidence in
other systems suggests that myoepithelial pericytes may affect capillary diameter in some
cases (Schonfelder et al., 1998). Thus, control experiments were done to determine
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whether this variation in blood vessel diameter was due to true growth of endothelium or
to short-term action of hormones and neurotransmitters on contractile elements.
Effect of histamine treatment on ovarian follicle blood vessel diameter
The effect of histamine, which dilates blood vessels by acting on vascular smooth
muscle cells and pericytes (Wahl and Kuschinsky, 1979), was determined by applying the
drug (30 µl of 13.3 mg/ml) in vitro on follicle-enclosed oocytes dissected from
Tg(fli1:EGFP)y1 zebrafish. Vessel diameter quantified from images captured one per
minute did not change significantly in response to histamine treatment (Fig. 20).

Effect of acetylcholine treatment on ovarian follicle blood vessel diameter
Acetylcholine induces dilation of blood vessels by acting on muscarinic receptors
on endothelial cells leading to relaxation of the vascular smooth muscles (Furchgott and
Zawadzki, 1980). Acetylcholine (1.66 µg at 66 µg/ml) did not significantly change blood
vessel diameter of follicle-enclosed oocytes dissected from Tg(fli1:EGFP)y1 zebrafish
(Fig. 21). No changes were also evident when acetylcholine concentration was raised to
10 mM.

Effect of epinephrine treatment on ovarian follicle blood vessel diameter
Epinephrine induces diameter changes of blood vessels by acting on adrenergic
receptors on smooth muscle cells (Gillespie and Hamilton, 1966). Epinephrine (183.2
ug/ml) did not cause any significant changes in blood vessel diameter on follicle-enclosed
oocytes dissected from Tg(fli1:EGFP)y1 zebrafish (Fig. 22).
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Effect of estradiol treatment on ovarian follicle blood vessel diameter
While it is known that estradiol is important in ovarian development and
maturation, information on the effect of estradiol on blood vessels in zebrafish ovarian
follicles is not available. However, in other systems, estradiol may act on nitric oxide
pathways to affect blood vessel diameter (Lang et al., 1997; McNeill et al., 2002).
Estradiol (37 µg/ml) did not significantly change ovarian blood vessel morphology in
follicle enclosed oocytes from Tg(fli1:EGFP)y1 zebrafish (Fig. 23). The lack of a
response persisted for more than 40 minutes after estradiol treatment.

3. Effect of hormone treatment on ovarian development

Estradiol treatment
Estradiol is an important hormone involved in ovarian development and
maturation. Hence, to determine whether addition of exogenous estradiol changes ovarian
development and maturation, the hormone (10 µg/L) was added to fish tanks containing
Tg(fli1:EGFP)y1 zebrafish and the fish injected with TB one day later. But within three
days of adding estradiol, all five the treated fish died. The cause of death may be the
combined effects of high estradiol levels and TB injection.

Tamoxifen treatment
The effect of tamoxifen, a competitive antagonist of estradiol, on zebrafish
development was determined by treating Tg(fli1:EGFP)y1 zebrafish with the agent and
then injecting TB one day later. In fish treated with a low dose of tamoxifen (5 µg/L) and
injected with TB, ovaries dissected at 48 hours after injection were stained blue (Fig. 24).
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However, these ovaries appeared similar to those dissected from tamoxifen treated
zebrafish, but not injected with TB (Fig. 25). In response to tamoxifen treatment, the GFP
fluorescence in ovarian follicles deteriorated (Figs. 24 and 25). The deterioration was
similar in both TB-injected and TB-free fish, suggesting that TB injection may not have
been the reason for the lack of GFP fluorescence in ovarian follicles.
At a higher dose of tamoxifen (50 µg/L), ovaries of the treated Tg(fli1:EGFP)y1
zebrafish appeared to be cytolysing and contained only a few small blue follicle-enclosed
oocytes (Fig. 26). Further, the big follicles appeared to be detached and lying free within
the lumen. Also, the ovaries appeared deteriorated and disintegrating with many dead and
cytolyzing ovarian follicles evident. In addition, the TB fluorescence was low (Fig. 26).
In addition, to determine the long term effects of low dose tamoxifen (5 µg/L),
ovaries of tamoxifen-treated Tg(fli1:EGFP)y1 zebrafish, were examined at 72 hours, 96
hours, and 8 days after treatment (Fig. 27). At 72 hours post-treatment the ovarian
integrity was poor and the ovaries appeared deteriorated. The large follicles appeared
detached and lying loose within the lumen. At 96 hours post treatment, detached follicles
similar to that seen at 72 hours were evident. In addition, resorption of ovarian follicles
was pronounced; resorbing follicles were collapsed with irregular outlines and were no
longer spherical. A similar resorption of ovarian follicles was also seen in ovaries
dissected 8-days after tamoxifen treatment. At all time points, the morphology of blood
vessels appeared distorted.

Changes in ovarian follicle growth and development in casper transgenic zebrafish
The casper transgenic zebrafish is mostly transparent and hence, ovaries are
visible inside the zebrafish. This eliminated the need to sacrifice females to dissect
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ovaries to study their growth and development. Importantly, casper fish also allowed
longitudinal study of ovarian changes with time in vivo. Ovarian follicles in the same
casper zebrafish were imaged for more than 7 weeks at regular intervals. A montage of
the images show development of ovarian follicles over time (Fig. 28). The developmental
phase is followed by a regression phase during which the ovarian follicles do not develop
but regress. After several days in the regression phase, the development phase restarts.
Diameters of follicle-enclosed oocytes calculated from brightfield images, show cyclic
diameter changes over a 30-day period (Fig. 29). Thus, the casper images suggest that
zebrafish ovarian follicles cycle naturally through development and regression periods
To determine the effect of tamoxifen on ovarian follicles using casper transgenic
zebrafish, we treated one fish with a low dose (5 µg/L) tamoxifen and another with a high
dose (50 µg/L) of tamoxifen. Examination of the ovaries after 7 days showed that the
ovaries had regressed in both fish (Fig. 30). In a control casper zebrafish not treated with
tamoxifen, some regression was also seen (Figs. 28, 29 and 30). However, the ovarian
follicles of the tamoxifen-treated fish did not cycle back to the development phase and
remained regressed. The control casper zebrafish ovaries cycled back to the development
phase as shown in Figures 28 and 29.
To further test if the tamoxifen effect on ovarian follicle regression was
permanent, casper zebrafish that were being treated with tamoxifen were removed and
placed in a tank without tamoxifen. Seven days after placing the fish in tamoxifen-free
tank, the ovarian follicles again began to develop, grow and fill with opaque yolk (Fig.
31). This suggested that the effect of tamoxifen was not permanent.
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While estradiol in vivo promotes ovarian growth and development in zebrafish, it
is not clear if estradiol in vitro has similar effects. To determine this, casper zebrafish
were placed in a tank containing estradiol (10 µg/L). However, as seen with
Tg(fli1:EGFP)y1 zebrafish, the casper zebrafish all died in a few days. Hence, the
concentration was lowered to 1 µg/L and the experiment repeated. In casper zebrafish
with gravid ovaries filled with large follicle-enclosed oocytes, seven days after estradiol
treatment the oocytes began to regress (Fig. 32) and remained in the regressed state as
long as estradiol was present in the tank. If the estradiol treatment was initiated when the
casper zebrafish follicle-enclosed oocytes were in a natural regressed state, then the
follicles remained in the regressed state (Fig. 33).
After maintaining the fish in the estradiol-containing tank for two weeks, they
were transferred to an estradiol-free tank. Soon after this transfer, the ovarian follicles
began to recover and develop, as similar to post-tamoxifen treatment, suggesting that the
effect of estradiol was not permanent (Fig. 34).
In additional experiments, the longer term exposure to exogenous estradiol was
explored. Observations in live female casper zebrafish placed in an estradiol-containing
tank for more than four weeks revealed regression of ovarian follicle development, as
seen for shorter term estradiol treatment. In addition, white structures similar to that of
zebrafish testis began to develop (Fig. 35). This gave the appearance that long-term
estradiol treatment led to development of male sex organs in female zebrafish. To check
if this was a real change, control male Tg(fli1:EGFP)y1 zebrafish were sacrificed and the
authentic testis dissected. Images of testis showed the presence of seminiferous tubules
with interspersed lipid (Fig. 36). Similarly, the estradiol-treated female zebrafish were
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sacrificed and the novel white tubular structure and the ovaries were dissected. The novel
white structure consisted of adipose tissue with clear lipid droplet inclusions. Images of
the ovaries revealed that there was severe regression of the ovarian follicles, with only
previtellogenic follicles detectable in the ovary (Fig. 37). Further, the gaps in the ovary
were filled with increasing amounts of adipose tissue (Fig. 37). In the intact fish, the
adipose tissue appeared to look like testis of male zebrafish (Fig. 35). Therefore, long
term estradiol treatment led to the regression of ovarian follicle development with
adipose tissue filling the gaps formed due to regression.
In additional experiments, casper transgenic zebrafish were injected (10%
injectate volume/body weight) with TB either at low (0.25% TB) or high dose (0.5% TB)
in order to follow the development of ovarian follicles via TB uptake in live zebrafish.
However, imaging the TB through the body wall was difficult and high background
obscured imaging the fluorescence of ovarian follicles, This was especially true when
imaging TB fluorescence, indicating that a different approach was needed.
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Discussion

In the current set of studies, wildtype, Tg(fli1:EGFP)y1, and casper zebrafish
were utilized to determine the time course of development of follicle-enclosed oocytes.
The main findings from these studies are, (1) uptake of TB into zebrafish follicleenclosed oocytes in vivo was maximum at 48 hours post-treatment, (2) development of
follicle blood vessels closely followed development of follicle-enclosed oocytes, and (3)
treatment of zebrafish with exogenous estradiol or its antagonist, suppressed follicular
development during the treatment period.

Evidence in support of trypan blue as a vitellogenin endocytosis probe
In the present experiments, TB was used as a fluorescent marker for oocyte
growth and development. TB has been used extensively for decades as a marker for cell
viability (Hathaway et al., 1964; Pachman et al., 1971; Ward and Becker, 1967). Thus,
TB exclusion assay is a standard way to distinguish between healthy, and damaged or
dead cells. Paradoxically, TB incorporates into vertebrate oocytes as previously reported
(Anderson and Telfer, 1970; Callebaut et al., 1981; Selman and Wallace, 1983). These
studies also suggest that incorporation of TB into living oocytes is linked to oocyte
uptake of vitellogenin and the inclusion of TB into oocytes does not simply imply
damaged or dead oocytes. This conclusion is supported by preliminary experiments that
show injection of TB into gravid female zebrafish, results in oviposition of TBcontaining eggs which when fertilized, develop into healthy embryos. Importantly, in the
embryos, TB is localized to the yolk cell and excluded from the embryonic cells (Fig.
38). This localization continues into the larval stage (Fig. 39).
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Confocal images of the embryos indicate the typical red fluorescence only in the
yolk globules (Figs. 40, 41) and not in the ooplasm of the oocyte. These results support
the hypothesis that TB incorporation is primarily coupled with vitellogenin uptake in
oocytes and the TB appears to colocalize with the processed vitellogenin (i.e. lipovitellin
and phosvitin) in membrane enclosed yolk vesicles. Further, these experiments also show
that TB uptake itself does not limit oocyte growth or embryonic development and thus is
non-toxic to the animal and its cells.
Thus, broadly it appears that TB has contrasting functions. The marker the reports
extent of cell damage and death in one assay, while it reports growth and development in
another assay. This difference could be explained via the duration for which the two
assays are performed. For TB exclusion assay, the typical incubation time of the cells
with the marker is 15 minutes or less (Hathaway et al., 1964; Pachman et al., 1971; Ward
and Becker, 1967). Accordingly, in the present studies no TB fluorescence was evident in
oocytes dissected at 1 hour post TB injection. This clearly suggests that the oocytes were
not damaged or dead and the intact living cell excluded short-term TB uptake. In contrast,
TB fluorescence was high in oocytes dissected after several hours or days post injection.
Thus, over longer durations in the hours or days range, TB likely works as a marker of
protein uptake via receptor-mediated endocytosis, as evidenced by its specific
localization in vitellogenic membrane-bound yolk vesicles. Thus, the contrasting results
obtained with TB depends on whether its presence inside cells is detected within minutes,
indicating reduced cell membrane continuity, or over hours and days, indicating
endocytotic activity.
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Trypan blue uptake into follicle-enclosed oocytes
In both wild-type and Tg(fli1:EGFP)y1 zebrafish, intraperitoneal injection of TB
resulted in a maximum increase in fluorescence in follicle-enclosed oocytes at 48 hours
post injection. Both at earlier and later time points, the fluorescence in follicle-enclosed
oocytes was less than at 48 hours. Thus, measurements made before 48 hours showed that
the fluorescence increased gradually with time, while those made after 48 hours showed
that the fluorescence declined gradually with time post injection. Therefore, taken over
the entire duration, the data suggest that injection of TB led to a gradual increase in
follicle-enclosed oocyte fluorescence that peaked at 48 hours, followed by a decline.
The increase in fluorescence in follicle-enclosed oocytes following TB injection
suggests uptake of TB into the oocytes. TB has been used extensively as a marker for
oocyte development in several other vertebrates (Callebaut et al., 1981; Gutzeit and
Arendt, 1994; Harrisson et al., 1981; Isayeva et al., 2004; Selman and Wallace, 1983;
Wajc et al., 1977). Exposing live ovarian follicles to TB causes its incorporation into
oocytes (Anderson and Telfer, 1970; Danilchik and Denegre, 1991). Using Japanese
quail, it was shown that even at low concentrations, TB is taken up into oocytes
(Harrisson et al., 1981). Further, the same study also showed that TB fluorescence in
oocytes is concentration dependent (Harrisson et al., 1981). The in vitro assay in the
present study also showed that TB fluorescence increases with concentration. Also, TB
fluorescence was detectable only when the marker was bound to a protein and increased
with increasing protein concentration. Therefore, high TB fluorescence in follicleenclosed oocytes suggests high incorporation of TB and its high association with yolk
proteins in the oocyte.
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Thus, the time-dependent increase in TB fluorescence up to 48 hours suggests a
time-dependent increase in TB incorporation into the follicle-enclosed oocytes. TB
incorporation in oocytes of other vertebrates is linked to uptake of the yolk protein,
vitellogenin into the oocytes (Anderson and Telfer, 1970; Callebaut et al., 1981; Gutzeit
and Arendt, 1994; Selman and Wallace, 1983). Therefore, an increase in vitellogenin
accumulation can lead to increase in TB accumulation, and increased TB fluorescence.
During development of follicle-enclosed oocytes, vitellogenin accumulation and increase
in oocyte size is highest during stage 3 (Clelland and Peng, 2009; Lessman, 1999, 2009;
Lubzens et al., 2010; Matsuda et al., 2011; Selman and Wallace, 1983). The results in this
study show that TB fluorescence was highest in 300-500 micron diameter oocytes.
Oocytes in this diameter range are likely to be in stage 3 in teleost fish (Lessman, 1999,
2009; Selman and Wallace, 1983). Hence in the present study, it is likely that follicleenclosed oocytes with high TB fluorescence were in the vitellogenic phase. So it follows
that the gradual increase in TB fluorescence is a direct indication of the gradual
development of vitellogenin accumulation in follicle-enclosed oocytes. In other words,
the time line of changes in TB fluorescence in follicle-enclosed oocytes provide a new
method to establish the time line of development of these oocytes. Thus, the current
studies suggest that vitellogenin uptake reaches a maximum in oocytes presumably at 48
hours after introduction via injection ip. These time-line data match findings reported in
a recent publication showing uptake of FITC-labeled goldfish vitellogenin into zebrafish
ovarian follicles (Matsuda et al., 2011). The similar TB uptake characteristics in both
wild-type and Tg(fli1:EGFP)y1 zebrafish indicate that ovarian development in transgenic
zebrafish was similar to that in the wildtype zebrafish. Hence, other ovarian development
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data obtained using Tg(fli1:EGFP)y1 zebrafish in the present set of studies should be
representative for zebrafish in general.
In addition, the TB fluorescence was also lower in follicle-enclosed oocytes
dissected at time points after 48 hours. The cause for this decline is not clear. It may be
that TB dissociates from vitellogenin, during the enzymatic processing of vitellogenin in
the endo-lysosome vesicles. The gradual decline in fluorescence may be due to the
gradual breakdown of vitellogenin by enzymatic processing. In addition, with increasing
time, vitellogenin may migrate deeper into follicle-enclosed oocytes as it is processed
into lipovitellin and phosvitin and stored in membrane-bound yolk vesicles. Hence, TB
associated with vitellogenin also moves to those deeper layers as vesicle trafficking
occurs. Thus, the excitation light and emission fluorescence must travel longer distances
through the yolk-filled ooplasm and hence, the TB fluorescence at the surface of follicleenclosed oocytes may appear low. Additional studies are needed to further determine
which of the above two possibilities contribute to the decline in TB fluorescence at time
points beyond 48 hours after TB injection.
While TB injection into zebrafish caused an increase in fluorescence in follicleenclosed oocytes, FITC-casein, FITC-lectin, and mCherry injection did not cause any
change in fluorescence. These results suggest that only TB was taken up into oocytes, and
the other markers were not. In previous studies, TB was present between the follicular
epithelial cells, suggesting that the dye moves through the various layers of the ovarian
follicle via a similar path used by vitellogenin (Anderson and Telfer, 1970). The exact
reason for non-uptake of the other markers needs additional studies, but endocytotic
receptor specificity is a likely factor.
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Blood vessel diameter response to exogenous agents
Since blood vessels of Tg(fli1:EGFP)y1 zebrafish exhibit GFP fluorescence,
vessel morphology and diameter were detectable using epifluorescence microscopy.
These data showed a possible association of larger blood vessels with larger ovarian
follicles. However, ovarian follicles of similar diameter had blood vessels over a wide
diameter range. No association was detectable between the percentage of GFP
fluorescence in the blood vessels and ovarian diameter. Overall, these data point to nonuniformity in blood vessel diameter in ovarian follicles.
The differences in blood vessel diameter may be due to blood vessel growth.
Angiogenesis involves growth of new blood vessels. In other species, ovarian
angiogenesis has been studied extensively and reviewed (Fraser, 2006; Leali et al., 2012;
Plendl, 2000; Reynolds et al., 2002). Addition of endogenous endothelial cells to newly
forming blood vessels causes changes in diameter. Hence, it is possible that the
variability in blood vessel diameter in Tg(fli1:EGFP)y1 zebrafish ovarian follicles may
be due to angiogenesis.
Another possibility for the variation in blood vessel diameter may be the action of
agents that act locally on blood vessels and induce vessel contraction or dilation. Agents
such as histamine, acetylcholine, epinephrine, and estradiol induce diameter changes in
blood vessels (Furchgott and Zawadzki, 1980; Gillespie and Hamilton, 1966; Lang et al.,
1997; Ross and Klebanoff, 1967; Wahl and Kuschinsky, 1979). However, they act on
smooth muscle cells of the blood vessels to induce changes in diameter. The images
captured from Tg(fli1:EGFP)y1 zebrafish show that ovarian blood vessel diameters are in
the 5-15 micron range. The small diameters of the blood vessels suggest that they may be
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capillaries. Capillaries do not have surrounding smooth muscle cells, but are associated
with smooth muscle like cells called pericytes (Bruns and Palade, 1968; Murakami et al.,
1979; Tsukada et al., 1996) that may be involved in modifying capillary diameters
(Kawamura et al., 2004; Reynolds et al., 2000; Schonfelder et al., 1998).
Addition of any of the four blood vessel dimension modifying agents to follicleenclosed oocytes dissected from Tg(fli1:EGFP)y1 zebrafish did not cause any significant
change in ovarian blood vessel diameter. Hence, it can be concluded that differences in
blood vessel diameter in ovarian follicles of various diameters are not likely due to the
short term effect of the hormones and neurotransmitters on the contractile elements. The
observed changes in diameter are likely associated with the growth of blood vessels
together with the growth of ovarian follicles. Additional studies are required to confirm
this interpretation.

Effect of exogenous hormones on development of follicle-enclosed oocytes
Estradiol plays a major role in oocyte development and maturation. In this study,
the effect of exogenous estradiol and its antagonist, tamoxifen, on follicle-enclosed
oocyte growth and development were determined. The experiments were done using both
Tg(fli1:EGFP)y1 and casper zebrafish. The results showed that because the development
of follicle-enclosed oocytes in casper zebrafish could be directly visualized without the
need to sacrifice the fish, casper zebrafish can be a highly useful model in ovarian
development studies.
At high doses of 10 g/L, exogenous estradiol led to death of Tg(fli1:EGFP)y1
zebrafish. The reasons for this response were not entirely clear. However, exogenous
estradiol reportedly can increase vitellogenin synthesis, extravascular edema and kidney
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failure (van der Ven et al., 2007). These may have been the cause for the death of the
zebrafish in the present study and need further testing. At a lower dose of exogenous
estrogen (i.e. 1 g/L) all the zebrafish survived. It is possible that at this low dose, the
harmful side-effects of estradiol treatment on the kidney and blood vessels may have
been less severe allowing survival. Hence, further experiments to determine changes in
ovarian follicles were done at 1g/L estradiol 17.
At the lower exogenous dose of 1g/L, estradiol led to the regression in ovarian
development and this regression was maintained for the duration of the estradiol
treatment. This interpretation is supported by the smaller size of the follicle-enclosed
oocytes in casper zebrafish. Production of endogenous estradiol is under the control of
follicle-stimulating hormone generated by the pituitary. Follicle-stimulating hormone acts
on theca cells of the ovary to induce estrogen production (Clelland and Peng, 2009;
Lubzens et al., 2010). Hence, addition of exogenous estradiol may act in a feedback
manner to shutdown follicle-stimulating hormone production. This could then lead to
lower endogenous production of estrogen and hence, stop vitellogenin production and
development of follicle-enclosed oocytes. However, this pathway needs verified in future
experiments.
Tamoxifen, initially known as a nonsteroidal antiestrogen but now classified as a
selective estrogen receptor modulator (SERM), is used to treat breast cancer in pre and
postmenopausal patients (Jordan, 2003). In this study tamoxifen treatment caused a
regression of ovarian development in zebrafish. This regression is possible because
tamoxifen competitively inhibits estrogen binding to its receptors. But, tamoxifen
treatment increases the circulating levels of estrogen (Iino et al., 1991; Jordan, 2003).
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Therefore, the high estrogen level may act in a feedback mechanism to block luteinizing
hormone production in the pituitary gland. Luteinizing hormone is involved in ovarian
maturation (Clelland and Peng, 2009; Lubzens et al., 2010). This may be the reason for
the sustained lack of ovarian development in response to tamoxifen treatment. Another
possibility is that tamoxifen may be acting as an agonist as similar to estradiol, leading to
similar regressive effects on oocyte development. The higher estradiol produced due to
tamoxifen treatment may also have increased edema of the ovarian blood vessels and this
may have caused the blood vessels in images of Tg(fli1:EGFP)y1 zebrafish ovarian
follicles to appear disorganized. However, these possibilities need to be tested in future
experiments.
The present experiments also show that reversing the prolonged treatment with
either estradiol or tamoxifen, leads to reversing of the ovarian development status i.e., the
effects of exogenous estradiol and tamoxifen were reversible. This reversibility lends
additional support to the interpretation that estradiol and tamoxifen caused ovarian
regression by blocking follicle-stimulating hormone and luteinizing hormone production
in the pituitary rather than by causing damage to the ovarian follicles. Again, this
possibility needs to be confirmed in future experiments.
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Conclusion

In conclusion, the present sets of experiments provide a time-line of oocyte
growth, vitellogenin endocytosis, and follicle-enclosed oocyte development in zebrafish
using an exogenous marker, TB. The results of vascular morphometrics provide some of
the first data on vascularization of the different size classes of zebrafish follicle-enclosed
oocytes. The experiments also suggest that exogenous hormones may disrupt the natural
growth and development cycle of ovarian follicles in zebrafish. Thus, these studies
provide the foundation, and have developed the tools, for additional studies to define
mechanisms associated with follicle-enclosed oocyte development and its regulation in
zebrafish.
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Fig. 1. Stages of oogenesis in zebrafish. Top. Microscopic images of oocytes isolated
from zebrafish ovaries at different stages of development. Bottom. A schematic
representation of stages in fish oocyte development (reprinted from Lubzens, E., Young,
G., Bobe, J., Cerda, J., 2010. Oogenesis in teleosts: how eggs are formed. General and
comparative endocrinology 165, 367-389. with kind permission from Springer
Science+Business Media B.V)
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Fig. 2. Schematic representation of vitellogenesis and receptor mediated endocytosis
in oocytes (reprinted with from www.springerimages.com/Images/Chemistry/1-10.10
07_s11665-008-9281-x-5) with kind permission from Springer Science+Business
Media B.V).
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Fig. 3. Schematic representation of ovarian wall components (from brook trout). OE
- ovarian epithelium; TF- theca folliculi; FE - follicle cell epithelium; C - chorion
(reprinted with permission from Lessman et al. Can J Fish Aquat Sci. Vol 42, 1985).
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100 µm
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Fig. 4. Trypan blue uptake in zebrafish oocytes. Representative fluorescence (top) and
brightfield (bottom) images show trypan blue uptake into oocytes at 48 hours after TB
treatment. Note trypan blue stained oocytes appear blue in the brightfield image.
Arrows show examples of oocyte diameter measurement sites marked using the
calibrated Line Tool in ImageJ.
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Fig. 5. Background fluorescence in zebrafish ovarian follicles. A: Brightfield (left)
and fluorescence (right) images of ovarian follicles from fish not subjected to any
injection. Arrows show examples of oocyte diameter measurement sites marked
using the calibrated Line Tool in ImageJ. B: Plot at bottom shows fluorescence in
ovarian follicles as a function of their diameter.
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Fig. 6. Trypan blue fluorescence at 1 hour post injection. A: Brightfield (left) and
fluorescence (right) images of ovarian follicles in an ovary examined 1 hour after
trypan blue injection into the zebrafish. Arrows show examples of oocyte diameter
measurement sites marked using the calibrated Line Tool in ImageJ. B: Plot at
bottom shows fluorescence in ovarian follicles as a function of their diameter.

46

800

A

100 µm

100 µm

trypan blue fluorescence intensity
(gray levels)

B
300

linear fit
oocyte diameter vs trypan blue intensity
95% confidence band

250

r = 0.20005

200
150
100
50
0

0

200

400

600

800

oocyte diameter (microns)
Fig. 7. Trypan blue fluorescence at 24 hour post injection. A: Brightfield (left) and
fluorescence (right) images of ovarian follicles in an ovary dissected 24 hours after
trypan blue injection into the zebrafish. Arrows show examples of oocyte diameter
measurement sites marked using the calibrated Line Tool in ImageJ. B: Plot at
bottom shows fluorescence in ovarian follicles as a function of their diameter.
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Fig. 8. Trypan blue fluorescence at 48 hour post injection. A: Brightfield (left) and
fluorescence (right) images of ovarian follicles in an ovary dissected 48 hours after
trypan blue injection into the zebrafish. Arrows show examples of oocyte diameter
measurement sites marked using the calibrated Line Tool in ImageJ. B: Plot at
bottom shows fluorescence in ovarian follicles as a function of their diameter.
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Fig. 9. Trypan blue fluorescence at 96 hour post injection. A: Brightfield (left) and
fluorescence (right) images of ovarian follicles in an ovary dissected 4 days after
trypan blue injection into the zebrafish. Arrows show examples of oocyte diameter
measurement sites marked using the calibrated Line Tool in ImageJ. B: Plot at
bottom shows fluorescence in ovarian follicles as a function of their diameter.
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Fig. 10. Background fluorescence Tg(fli1:EGFP)y1 zebrafish. Fluorescence in
ovarian follicles from Tg(fli1:EGFP)y1 zebrafish that were not injected with any
trypan blue. Graph shows fluorescence in ovarian follicles as a function of their
diameter.
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Fig. 11. Fluorescence in Tg(fli1:EGFP)y1 zebrafish ovarian follicles removed 24
hours after trypan blue injection. Graph shows fluorescence in ovarian follicles as a
function of their diameter. (n = 3 zebrafish)
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Fig. 12. Fluorescence from Tg(fli1:EGFP)y1 zebrafish ovarian follicles
examined 48 hours after trypan blue injection. Graph shows fluorescence in
ovarian follicles as a function of their diameter. (n = 2 zebrafish)
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Fig. 13. Fluorescence from Tg(fli1:EGFP)y1 zebrafish ovarian follicles examined 96 hours
after trypan blue injection. Graph shows fluorescence in ovarian follicles as a function of
their diameter.
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Fig. 14. Fluorescence from Tg(fli1:EGFP)y1 zebrafish ovarian follicles examined 8
days after trypan blue injection. Graph shows fluorescence in ovarian follicles as a
function of their diameter.
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Fig. 15. Fluorescence from Tg(fli1:EGFP)y1 zebrafish ovarian follicles examined
14 days after trypan blue injection. Graph shows fluorescence in ovarian follicles as
a function of their diameter.
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Fig. 16. Trypan blue binding to bovine serum albumin. Different concentrations of
trypan blue were mixed with bovine serum albumin (BSA) in a 96-well plate as in fig.
13 and the fluorescence of each well was read. The image shows raw fluorescence in
the wells taken using the rhodamine filter (above dotted line) and FITC filter (below
dotted line). Note no fluorescence was detectable in the FITC channel. The plot shows
changes in trypan blue fluorescence (rhodamine channel) as a function of BSA
concentration.
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Fig. 17. Uptake of other fluorescent probes. A: Top two image sets show oocytes
dissected from mCherry injected wildtype zebrafish. mCherry fluorescence should be
visible in the red channel (center). Green channel indicates fluorescence spill over into
that channel. B: Bottom images show oocytes dissected from FITC-caesein injected
wildtype zebrafish. FITC-lectin fluorescence should be visible in the green channel
(far right).

57

A

100 µm

100 µm

100 µm

100 µm

B
blood vessel diameter
(microns)

20

linear fit
oocyte diameter vs vessel diameter
95% confidence band

15

r = 0.5962

10

5

0
0

200

400

600

800

1000

oocyte diameter (microns)
Fig. 18. Blood vessel characteristics in Tg(fli1:EGFP)y1 zebrafish ovarian follicles.
A: Epi-fluorescence images (top) show blood vessels over follicle-enclosed oocytes
from fli1-GFP zebrafish. B: Graph (bottom) shows ovarian follicle blood vessel
diameter as a function of the respective ovarian follicle diameter. (n = 4 zebrafish)
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Fig. 19. GFP fluorescence Tg(fli1:EGFP)y1 zebrafish ovarian follicle blood vessels.
Graph shows percentage of GFP fluorescence per unit area in ovarian blood vessels
as a function of oocyte diameter. (n = 2 zebrafish)
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Fig. 20. Temporal variation in histamine treated Tg(fli1:EGFP)y1 zebrafish ovarian
follicle blood vessels. A: Images show ovarian follicle blood vessels before, 5, 10 and
15 min after histamine treatment. B: Graph shows ovarian follicle blood vessel
diameter as a function of the time after histamine treatment (p>0.6 compared to 0
min).
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Fig. 21. Temporal variation in acetylcholine-treated Tg(fli1:EGFP)y1 zebrafish
ovarian follicle blood vessels. A: Images show ovarian follicle blood vessels before, 5,
10, and 15 min after acetylcholine treatment. B: Graph shows ovarian follicle blood
vessel diameter as a function of time after acetylcholine treatment (p>0.5 compared to
0 min)
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Fig. 22. Temporal variation in epinephrine-treated Tg(fli1:EGFP)y1 zebrafish ovarian
follicle blood vessels. A: Images show ovarian follicle blood vessels before, 5, 10, 15
and 25 min after epinephrine treatment. B: Graph shows ovarian follicle blood vessel
diameter as a function of the time after epinephrine treatment (p<0.01).
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Fig. 23. Temporal variation in estradiol-treated Tg(fli1:EGFP)y1 zebrafish ovarian
follicle blood vessels. A: Images show ovarian follicle blood vessels before, 10, 15
and 40 min after estradiol treatment. B: Graph shows ovarian follicle blood vessel
diameter as a function of the time after estradiol treatment (p>0.3 compared to 0 min).
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Fig. 24. Effect of Tamoxifen (low dose) treatment on Tg(fli1:EGFP)y1 zebrafish
injected with trypan blue. A: Brightfield image of follicle-enclosed oocytes at 48
hours after tamoxifen treatment. B: Trypan blue fluorescence in the same oocytes. C:
GFP fluorescence showing blood vessels. Note deterioration of ovarian follicles
(arrow). There is also a loss of blood vessels compared to control zebrafish (Fig. 18).
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Fig. 25. Effect of Tamoxifen (low dose) treatment on Tg(fli1:EGFP)y1 zebrafish not
injected with trypan blue. A: Brightfield image of follicle-enclosed oocytes at 48
hours after tamoxifen treatment. B: No fluorescence is evident in the trypan blue
fluorescence channel. C: GFP fluorescence showing blood vessels. Note deterioration
of ovarian follicles (arrow). There is also a loss of blood vessels compared to control
zebrafish (Fig. 18).
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Fig. 26. Effect of tamoxifen (high dose) treatment on Tg(fli1:EGFP)y1 zebrafish. A:
Brightfield image of follicle-enclosed oocytes at 48 hours after tamoxifen treatment.
B: Trypan blue fluorescence in the same oocytes. C: GFP fluorescence showing
blood vessels. Note deterioration of ovarian follicles (arrow) and the low trypan blue
fluorescence. There is also a loss of blood vessels compared to control zebrafish (Fig.
18).
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Fig. 27. Effect of tamoxifen (low dose) treatment on Tg(fli1:EGFP)y1 zebrafish at
different time intervals. A-C 72 hours post treatment. D-F: 96 hours post treatment.
G-I 8 days post treatment. A, D, G - Brightfield images of follicle-enclosed oocytes.
B, E, H: Trypan blue fluorescence in the corresponding oocytes. C, F, I: GFP
fluorescence showing blood vessels in the corresponding oocytes. Note deterioration
of ovarian follicles (arrows) and the low trypan blue fluorescence. There is also a loss
of blood vessels compared to control zebrafish (Fig. 18).
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Fig. 28. Temporal changes in follicle-enclosed oocytes of untreated casper
zebrafish. Brightfield images of intact untreated casper zebrafish taken on the days
indicated. Note natural cycling of the follicles between development and regression.
Days at which follicles are fully developed versus regressed are marked.
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Fig. 29. Analysis of temporal changes in follicle-enclosed oocytes of untreated casper
zebrafish. Follicle diameters measured every alternate day from brightfield images
were plotted to show changes during a one-month period. The red bars indicate
number of embryos spawned after crossing with male. The days during which the
diameters remained low suggest regression occurring naturally and marked as
“atresia”. X-axis denotes measurement dates. Y-axis denotes both follicle diameter
and embryo number.
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Fig. 30. Effect of tamoxifen on follicle-enclosed oocytes of casper zebrafish.
Brightfield images of intact untreated casper zebrafish taken on at 16 days after
treatment with tamoxifen (rows 2 and 3). Images in top row show changes in control
(untreated) zebrafish over the same period. Dose of tamoxifen is as indicated.
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Fig. 31. Reversal of tamoxifen- and estradiol-induced effects on casper zerbrafish.
casper zebrafish treated with tamoxifen or estradiol for 15 days were moved to a
tamoxifen- and estradiol-free tank. Brightfield images show follicle-enclosed oocytes
in casper zebrafish taken on different days during recovery in the hormone-free tank.
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Fig. 32. Effect of estradiol on casper zebrafish with developed follicle-enclosed
oocytes. Brightfield images show changes in follicle-enclosed oocytes in intact casper
zebrafish treated with estradiol for 9 days. The images taken at different time points
are as indicated.
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Fig. 33. Effect of estradiol on casper zebrafish with regressed follicle-enclosed
oocytes. Brightfield images show changes in follicle-enclosed oocytes in intact casper
zebrafish treated with estradiol for 9 days. The images taken at different time points
are as indicated.
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Fig. 34. Reversal of estradiol-induced effects on casper zerbrafish. casper zebrafish
treated with estradiol for 15 days were moved to an estradiol-free tank. Brightfield
images show changes in follicle-enclosed oocytes in casper zebrafish at different days
during treatment and recovery in the hormone-free tank.
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Fig. 35. Long term effect of estradiol on casper zebrafish. Brightfield images of an
intact female casper zebrafish treated with estradiol for 28 days show the
development of testis-like structures (n=4 fish).
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Fig. 36. Testis images from Tg(fli1:EGFP)y1 zebrafish. Brightfield images show
different views of testis dissected from male Tg(fli1:EGFP)y1 zebrafish. Note the
presence of seminiferous tubules in the testis. Also note the presence of lipid
associated with the organs. (n = 2 fish).
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Fig. 37. Ovarian follicles of casper zebrafish exposed to long term estradiol. Brightfield
images of ovarian follicles from casper zebrafish exposed to estradiol for 28 days were
taken at low (20x) and high (32x) magnifications. Note - at low magnification (top), a
thick layer of adipose tissue that looks similar to a testis is seen. The images at high
magnification (bottom) show the presence of previtellogenic follicles with germinal
vesicles and small follicles (n = 3 fish)
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Fig. 38. Trypan blue localizes to yolk in zebrafish embryos. Brightfield (top) and
fluorescence (bottom) images of embryos from trypan blue injected zebrafish show
localization of trypan blue fluorescence in yolk (white arrow) and its complete
exclusion from the embryonic cells (blue arrow).
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Fig. 39. Trypan blue localization in the larval stage of zebrafish embryos. Brightfield
(top left) and fluorescence (top right and bottom) images of larval stage embryos from
trypan blue injected Tg(fli1:EGFP)y1 zebrafish show localization of trypan blue (red)
fluorescence in yolk and its complete exclusion from other parts of the developing
larva. GFP fluorescence appears green in bottom image.
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Fig. 40. Confocal microscopy of trypan uptake into oocytes. Optical sections of
oocytes dissected from Tg(fli1:EGFP)y1 were obtained using confocal microscopy
and show fluorescence of trypan blue (red) and nuclear stain Hoeschst (blue). A, B.
Images show two different optical sections of oocytes dissected at 21 hours post
trypan blue injection. C. Image shows an optical section of oocytes dissected at 44
hours post trypan blue injection. Note trypan blue fluorescence is located in
membrane bound vesicles.
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Fig. 41. Confocal microscopy of trypan uptake into Tg(fli1:EGFP)y1 oocytes. Z-axis
projection of oocytes dissected from Tg(fli1:EGFP)y1 5 days after trypan blue
injection. The projection was reconstructed using optical sections from a confocal
microscope. Trypan blue fluorescence appears red, nuclear stain in blue, and vascular
GFP fluorescence in green.
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may not be altered in any manner. Abbrevia ons, addi ons, dele ons and/or any other altera ons shall be
made only with prior wri en authoriza on of the author and/or Springer Science + Business Media.
may not be republished in Electronic Open Access.

This permission
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a. is non‐exclusive.
b. includes use in an electronic form: provided it’s password protected, or on intranet or university’s
repository, including UMI (according to the defini on at the Sherpa website: h p://www.sherpa.ac.uk
/romeo/), or CD‐Rom/E‐book,
c. is subject to a courtesy informa on to the author (address is given with the ar cle/chapter).
d. is personal to you and may not be sublicensed, assigned, or transferred by you to any other person without
Springer's wri en permission.
e. is valid only when the condi ons noted above are met.

Permission free of charge on this occasion does not prejudice any rights we might have to charge for reproduc on
of our copyrighted material in the future.

Kind regards,
Maaike Duine

From: Gayathri Kaushik (gkaushik) [mailto:gkaushik@memphis.edu]
Sent: Tuesday, May 14, 2013 9:21 PM
To: Onlineservice, SCSC
Cc: Gayathri Kaushik (gkaushik)
Subject: RE: TN147626 image use permission

Dear Ms. Bontigao,
Thank you very much for your fast response. I am an University of Memphis, Tennessee, USA- Master's Student (
Department of Biology) and I as I mentioned in my earlier email, I would just like to use that one schematic
image only for my thesis write up work and not the whole set of figures. The reason being, I went through the
link you provided and it is requiring me to purchase for all the figures which I will not need.
Kindly advise. Thanks again for your prompt help.
Sincerely,
Gayathri
Master's Student
Department of Biology
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3774 Walker Avenue
Memphis, TN 38152-3530

From: Onlineservice, SCSC [Onlineservice@springer.com]
Sent: Tuesday, May 14, 2013 1:30 PM
To: Gayathri Kaushik (gkaushik)
Subject: RE: TN147626 image use permission

Dear Gayathri,

Thank you for your email.

The permission rights you can purchase directly on h p://link.springer.com .
On ar cle level you will find on the right side Reprints & Permissions.
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K Parthas <kxp128@gmail.com>

3. FW: Permission
Gayathri Kaushik (gkaushik) <gkaushik@memphis.edu>
To: "kxp128@gmail.com" <kxp128@gmail.com>

Thu, Jun 27, 2013 at 11:17 PM

From: pubs@nrcresearchpress.com [pubs@nrcresearchpress.com]
Sent: Wednesday, May 15, 2013 10:40 AM
To: Gayathri Kaushik (gkaushik)
Subject: RE: Permission

Dear Gayathri,

Thank you for your permission request.

Please consult:

http://nrcresearchpress.com/page/authors/services/reprints, specifically:

Anyone may reuse figures, tables, and short excerpts from any NRC Research Press article, for any
purpose that respects the moral rights of authors, at no charge and without permission.

If formal permission is required, please contact RightsLink by following the steps in the instructions on
that page.

Best regards,
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Eileen Evans‐Nantais

Client Service Representa ve
Canadian Science Publishing (NRC Research Press)
1200 Montreal Road, Building M‐55, O awa, ON K1A 0R6 Canada
T: 613‐990‐7873 | F: 613‐952‐7656
Website: www.nrcresearchpress.com

From: Gayathri Kaushik (gkaushik) [mailto:gkaushik@memphis.edu]
Sent: May-14-13 4:12 PM
To: pubs@nrcresearchpress.com
Cc: Gayathri Kaushik (gkaushik)
Subject: Permission

Dear Ms. Eileen Evans-Nantais,
I am an University of Memphis, Tennessee, USA- Master's Student ( Department of Biology). Dr. Lessman is my
Thesis Mentor and would just like to use one of his figures ( Figure 6) from Lessman et al. Can J Fish Aquat Sci.
Vol 42, 1985 for my Master's thesis write up work and not the whole set of figures. Could you kindly give me
permission to use the same. Kindly help.
Lessman et al. Can J Fish Aquat Sci. Vol 42, 1985 (Figure 6)

Look forward for a favorable reply.
Thank you for your time and attention to my request.
Sincerely,
Gayathri
Master's Student (Mentor- Dr. Lessman)
Department of Biology
3774 Walker Avenue
Memphis, TN 38152-3530
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